Legato Capital Management »

Theravance Biopharma shares owned by Legato Capital Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $489k 26k 18.71

More positions owned by Legato Capital Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Argan (AGX)
Ies Hldgs (IESC)
Alphabet Inc Class A cs (GOOGL)
Stonex Group (SNEX)
Microsoft Corporation (MSFT)
VSE Corporation (VSEC)
Amazon (AMZN)
Agilysys (AGYS)
Triumph Ban (TFIN)
Kratos Defense & Security Solutions (KTOS)
ePlus (PLUS)
UFP Technologies (UFPT)

View all positions for Legato Capital Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group

View all funds holding Theravance Biopharma